423 related articles for article (PubMed ID: 24294991)
1. Cell-specific and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer.
Tian J; Ding L; Xu HJ; Shen Z; Ju H; Jia L; Bao L; Yu JS
J Am Chem Soc; 2013 Dec; 135(50):18850-8. PubMed ID: 24294991
[TBL] [Abstract][Full Text] [Related]
2. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy.
Hou W; Zhao X; Qian X; Pan F; Zhang C; Yang Y; de la Fuente JM; Cui D
Nanoscale; 2016 Jan; 8(1):104-16. PubMed ID: 26607263
[TBL] [Abstract][Full Text] [Related]
3. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells.
Chen H; Tian J; He W; Guo Z
J Am Chem Soc; 2015 Feb; 137(4):1539-47. PubMed ID: 25574812
[TBL] [Abstract][Full Text] [Related]
4. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.
Jin CS; Cui L; Wang F; Chen J; Zheng G
Adv Healthc Mater; 2014 Aug; 3(8):1240-9. PubMed ID: 24464930
[TBL] [Abstract][Full Text] [Related]
5. Activatable albumin-photosensitizer nanoassemblies for triple-modal imaging and thermal-modulated photodynamic therapy of cancer.
Hu D; Sheng Z; Gao G; Siu F; Liu C; Wan Q; Gong P; Zheng H; Ma Y; Cai L
Biomaterials; 2016 Jul; 93():10-19. PubMed ID: 27061266
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Activated Water-Soluble Photosensitizers for Near-Infrared Photodynamic Cancer Therapy.
Xiong H; Zhou K; Yan Y; Miller JB; Siegwart DJ
ACS Appl Mater Interfaces; 2018 May; 10(19):16335-16343. PubMed ID: 29697248
[TBL] [Abstract][Full Text] [Related]
7. Efficient Near-Infrared Photosensitizer with Aggregation-Induced Emission for Imaging-Guided Photodynamic Therapy in Multiple Xenograft Tumor Models.
Dai J; Li Y; Long Z; Jiang R; Zhuang Z; Wang Z; Zhao Z; Lou X; Xia F; Tang BZ
ACS Nano; 2020 Jan; 14(1):854-866. PubMed ID: 31820925
[TBL] [Abstract][Full Text] [Related]
8. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
Wacker M; Chen K; Preuss A; Possemeyer K; Roeder B; Langer K
Int J Pharm; 2010 Jun; 393(1-2):253-62. PubMed ID: 20417701
[TBL] [Abstract][Full Text] [Related]
9. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
10. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway.
Hou Z; Zhang Y; Deng K; Chen Y; Li X; Deng X; Cheng Z; Lian H; Li C; Lin J
ACS Nano; 2015 Mar; 9(3):2584-99. PubMed ID: 25692960
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic HDL nanoparticle mediated tumor targeted delivery of indocyanine green for enhanced photodynamic therapy.
Wang Y; Wang C; Ding Y; Li J; Li M; Liang X; Zhou J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():533-540. PubMed ID: 27690242
[TBL] [Abstract][Full Text] [Related]
12. Sharp pH-sensitive amphiphilic polypeptide macrophotosensitizer for near infrared imaging-guided photodynamic therapy.
Yuan P; Ruan Z; Li T; Tian Y; Cheng Q; Yan L
Nanomedicine; 2019 Jan; 15(1):198-207. PubMed ID: 30316904
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles.
Wang C; Tao H; Cheng L; Liu Z
Biomaterials; 2011 Sep; 32(26):6145-54. PubMed ID: 21616529
[TBL] [Abstract][Full Text] [Related]
14. An upconversion nanoplatform with extracellular pH-driven tumor-targeting ability for improved photodynamic therapy.
Ai F; Wang N; Zhang X; Sun T; Zhu Q; Kong W; Wang F; Zhu G
Nanoscale; 2018 Mar; 10(9):4432-4441. PubMed ID: 29451577
[TBL] [Abstract][Full Text] [Related]
15. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
Zhang L; Zeng L; Pan Y; Luo S; Ren W; Gong A; Ma X; Liang H; Lu G; Wu A
Biomaterials; 2015 Mar; 44():82-90. PubMed ID: 25617128
[TBL] [Abstract][Full Text] [Related]
16. Dual-targeting nanosystem for enhancing photodynamic therapy efficiency.
Xu J; Zeng F; Wu H; Yu C; Wu S
ACS Appl Mater Interfaces; 2015 May; 7(17):9287-96. PubMed ID: 25876183
[TBL] [Abstract][Full Text] [Related]
17. A dual activatable photosensitizer toward targeted photodynamic therapy.
Lau JT; Lo PC; Jiang XJ; Wang Q; Ng DK
J Med Chem; 2014 May; 57(10):4088-97. PubMed ID: 24793456
[TBL] [Abstract][Full Text] [Related]
18. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation.
Vankayala R; Huang YK; Kalluru P; Chiang CS; Hwang KC
Small; 2014 Apr; 10(8):1612-22. PubMed ID: 24339243
[TBL] [Abstract][Full Text] [Related]
19. Poly(photosensitizer) Nanoparticles for Enhanced in Vivo Photodynamic Therapy by Interrupting the π-π Stacking and Extending Circulation Time.
Zheng N; Zhang Z; Kuang J; Wang C; Zheng Y; Lu Q; Bai Y; Li Y; Wang A; Song W
ACS Appl Mater Interfaces; 2019 May; 11(20):18224-18232. PubMed ID: 31046231
[TBL] [Abstract][Full Text] [Related]
20. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
